Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.65 |
| ▸ | HTT | P42858 | 2/20 | 0.65 |
| ▸ | LMNA | P02545 | 1/20 | 0.65 |
| ▸ | MEN1 | O00255 | 5/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.62 |
| ▸ | MAPT | P10636 | 3/20 | 0.62 |
| ▸ | AHR | P35869 | 1/20 | 0.62 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.62 |
| ▸ | HTR2A | P28223 | 5/20 | 0.59 |
| ▸ | HTR2C | P28335 | 4/20 | 0.59 |
| ▸ | HTR6 | P50406 | 4/20 | 0.59 |
| ▸ | HTR1A | P08908 | 4/20 | 0.59 |
| ▸ | HTR1D | P28221 | 3/20 | 0.59 |
| ▸ | HTR2B | P41595 | 3/20 | 0.59 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.59 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.59 |
| ▸ | HTR1E | P28566 | 2/20 | 0.59 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10382799 | 0.84 | MEN1 (0.67) | ALDH1A1HTTLMNAMEN1KMT2A | |
| Quinoline SCHEMBL28296371 | 0.83 | ALDH1A1 (0.48) | ALDH1A1HTTLMNAMEN1KMT2A | |
| SCHEMBL6803427 | 0.81 | MEN1 (0.58) | ALDH1A1HTTLMNAMEN1KMT2A | |
| SCHEMBL28231921 | 0.81 | MEN1 (0.58) | ALDH1A1HTTLMNAMEN1KMT2A | |
| SCHEMBL6157000 | 0.81 | HTR2A (0.65) | ALDH1A1HTTLMNAMEN1KMT2A | |
| SCHEMBL6156912 | 0.81 | MEN1 (0.58) | ALDH1A1HTTLMNAMEN1KMT2A | |
| SCHEMBL29376106 | 0.81 | MEN1 (0.62) | ALDH1A1HTTLMNAMEN1KMT2A | |
| SCHEMBL4656420 | 0.81 | MEN1 (0.62) | ALDH1A1HTTLMNAMEN1KMT2A | |
| SCHEMBL2485762 | 0.81 | MEN1 (0.62) | ALDH1A1HTTLMNAMEN1KMT2A | |
| SCHEMBL1327214 | 0.81 | MEN1 (0.62) | ALDH1A1HTTMEN1KMT2ACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 140 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116924964-A | Preparation method of tetrahydrocarbazole ring compound | 四川轻化工大学 | 2023-10-24 | — | — | CN | claimed |
| CN-114702429-B | Method for constructing 3-alkyl indole compounds by olefin difunctional | 南昌航空大学 | 2023-06-02 | — | — | CN | claimed |
| CN-114702429-A | Method for constructing 3-alkyl indole compound by olefin dual-functionalization | 南昌航空大学 | 2022-07-05 | — | — | CN | claimed |
| CN-114014859-A | Triazole indolol compound and synthesis method thereof | 绍兴文理学院 | 2022-02-08 | — | — | CN | claimed |
| CN-112876401-A | Synthesis method of chiral 3-allylindole compound | 江苏师范大学 | 2021-06-01 | — | — | CN | claimed |
| CN-101245046-B | 3-indole-1-propylene compounds, process for synthesizing 3-indole-1-propylene compounds and uses thereof | SHANGHAI INST ORGANIC CHEM | 2011-04-06 | — | — | CN | claimed |
| CN-101245046-A | Process for synthesizing 3-indole-1-propylene compounds and uses thereof | SHANGHAI INST ORGANIC CHEM (CN) | 2008-08-20 | — | — | CN | claimed |
| WO-2003018192-A2 | METHOD FOR THE PRODUCTION OF 2-PROPYLHEPTANOL AND HYDROFORMYLATING CATALYSTS AND THE FURTHER USE THEREOF FOR CARBONYLATION, HYDROCYANATION AND HYDROGENATION | BASF AKTIENGESELLSCHAFT (DE) | 2003-03-06 | — | — | WO | claimed |
| EP-0758893-A1 | POTENTIATED ANTIBIOTIC COMPOSITION | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1997-02-26 | — | — | EP | claimed |
| WO-1995030417-A1 | POTENTIATED ANTIBIOTIC COMPOSITION | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1995-11-16 | — | — | WO | claimed |
| WO-2024148030-A1 | KETO ACID BIOPOLYMERS AND POLYOL KETO ESTERS AND USES THEREOF | ATOSSA THERAPEUTICS, INC. (US) | 2024-07-11 | — | — | WO | disclosed |
| US-20240131005-A1 | COMPOSITIONS AND METHODS FOR TREATING NON-HEMORRHAGIC CLOSED HEAD INJURY | BOULDER BIOSCIENCE LLC | 2024-04-25 | — | — | US | disclosed |
| WO-2024073473-A1 | COMPOSITIONS COMPRISING 3,3'-DIINDOLYLMETHANE FOR TREATING NON-HEMORRHAGIC CLOSED HEAD INJURY | BOULDER BIOSCIENCE LLC (US) | 2024-04-04 | — | — | WO | disclosed |
| CN-117417253-A | Method for preparing phenyl alkyl acid ester by alkyl olefin | 常州大学 | 2024-01-19 | — | — | CN | disclosed |
| CN-117186089-A | Preparation method of tetrahydrocarboline derivative | 浙江大学 | 2023-12-08 | — | — | CN | disclosed |
| WO-1996010014-A1 | ALDEHYDE DERIVATIVES AS UPSTEINE PROTEASE INHIBITORS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1996-04-04 | — | — | WO | disclosed |
| WO-1995030417-A1 | POTENTIATED ANTIBIOTIC COMPOSITION | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1995-11-16 | — | — | WO | disclosed |
| EP-0421441-B1 | Pantothenic acid derivatives | FUJIREBIO KK (JP) | 1995-01-25 | — | — | EP | disclosed |
| US-5120738-A | Cardiovascular disorders | FUJIREBIO INC. (JP) | 1992-06-09 | — | — | US | disclosed |
| EP-0421441-A2 | Pantothenic acid derivatives | FUJIREBIO INC. (JP) | 1991-04-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240131005-A1 | COMPOSITIONS AND METHODS FOR TREATING NON-HEMORRHAGIC CLOSED HEAD INJURY | NOTCH3, C1S, ADAM33 | ALDH1A1 3016/4885HTT 967/4885LMNA 683/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.